Sector Chart Merrimack Pharmaceuticals, Inc.

Equities

MACK

US5903282094

Delayed Nasdaq 16:00:00 2024-05-17 EDT 5-day change 1st Jan Change
15.13 USD -0.13% Intraday chart for Merrimack Pharmaceuticals, Inc. -.--% +12.83%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
224M - - - - -
44.44B -
39.84B
37.68B
31.46B -
27.02B